{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:14:36Z","timestamp":1767651276527,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.msard.2021.102913","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T03:20:12Z","timestamp":1616124012000},"page":"102913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["How the COVID-19 Pandemic has changed multiple sclerosis clinical practice: Results of a nationwide provider survey"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5018-0351","authenticated-orcid":false,"given":"Elizabeth H.","family":"Morrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelyn","family":"Michtich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie M.","family":"Hersh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2021.102913_bib0001","article-title":"Decision-making on management of MS and NMOSD patients during the COVID-19 pandemic: a Latin American survey","volume":"44","author":"Alonso","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2021.102913_bib0002","doi-asserted-by":"crossref","first-page":"e761","DOI":"10.1212\/NXI.0000000000000761","article-title":"COVID-19 and MS disease-modifying therapies","volume":"7","author":"Berger","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.msard.2021.102913_bib0003","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.0000000000009507","article-title":"Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic","volume":"94","author":"Brownlee","year":"2020","journal-title":"Neurol"},{"key":"10.1016\/j.msard.2021.102913_bib0005","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1590\/s1678-9946202062043","article-title":"Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis","volume":"62","author":"Espinosa","year":"2020","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.msard.2021.102913_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102073","article-title":"The COVID-19 pandemic and the use of MS disease-modifying therapies","volume":"39","author":"Giovannoni","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"11","key":"10.1016\/j.msard.2021.102913_bib0007","doi-asserted-by":"crossref","DOI":"10.2196\/22280","article-title":"Adoption of digital technologies in health care during the COVID-19 pandemic: systematic review of early scientific literature","volume":"22","author":"Golinelli","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.msard.2021.102913_bib0008","article-title":"COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments","author":"Laroni","year":"2020","journal-title":"Mult Scler"},{"issue":"12","key":"10.1016\/j.msard.2021.102913_bib0009","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1007\/s00415-020-10045-9","article-title":"Impact of COVID-19 on U.S. and Canadian neurologists\u2019 therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices","volume":"267","author":"Mateen","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.msard.2021.102913_bib0010","article-title":"Healthcare professionals\u2019 perceptions of critical care resource availability and factors associated with mental well-being during COVID-19: Results from a U.S. survey","author":"Sharma","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.msard.2021.102913_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/ana.26028","article-title":"Disease-modifying therapies and coronavirus disease 2019 severity in multiple sclerosis","author":"Sormani","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.msard.2021.102913_bib0004","unstructured":"Dean, A.G., Sullivan, K.M., Soe, M.M. OpenEpi: Open Source Epidemiologic Statistics for Public Health 2006, Version. www.OpenEpi.com, updated 2013\/04\/06, accessed 2021\/01\/02."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821001802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821001802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:55:36Z","timestamp":1761900936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821001802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":11,"alternative-id":["S2211034821001802"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.102913","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How the COVID-19 Pandemic has changed multiple sclerosis clinical practice: Results of a nationwide provider survey","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.102913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102913"}}